Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled
Modify Date: 2025-08-25 12:05:34
Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled structure
|
Common Name | Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled | ||
|---|---|---|---|---|
| CAS Number | 1815618-06-4 | Molecular Weight | 3306.739 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C137H217N47O41S4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeledAtrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled, one of three mammalian natriuretic peptides (NPs), has endocrine effects on fluid homeostasis and blood pressure. Atrial Natriuretic Peptide has the potential for cardiovascular diseases research[1][2]. |
| Name | Biotinyl-Atrial Natriuretic Factor (1-28) (human) trifluoroacetate salt |
|---|
| Description | Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled, one of three mammalian natriuretic peptides (NPs), has endocrine effects on fluid homeostasis and blood pressure. Atrial Natriuretic Peptide has the potential for cardiovascular diseases research[1][2]. |
|---|---|
| Related Catalog | |
| References |
[1]. S Vink, et al. Natriuretic peptide drug leads from snake venom. . 2012 Mar 15;59(4):434-45. |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Molecular Formula | C137H217N47O41S4 |
| Molecular Weight | 3306.739 |
| Exact Mass | 3304.522217 |
| LogP | -14.00 |
| Index of Refraction | 1.699 |
| InChIKey | HDTMXJVYSAVVRC-STPZZZDRSA-N |
| SMILES | CCC(C)C1NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)CCCCC2SCC3NC(=O)NC32)CSSCC(C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(Cc2ccccc2)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc2ccc(O)cc2)C(=O)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CO)NC(=O)C(CCC(N)=O)NC(=O)C(C)NC(=O)CNC1=O |